Christophe Berthoux

Christophe Berthoux is a seasoned executive with extensive experience in the healthcare and clinical research industries. Currently serving as the Founder and Board Member of FutureMeds since September 2020 and as Chairman of the Board for the IMAGE ANALYSIS GROUP since September 2018, Christophe has also held the position of Chief Executive Officer at NAMSA from March 2021 to May 2024. Previous roles include Non-Executive Director at Citoxlab and Chief Executive Officer at Synexus Clinical Research Ltd. From January 2005 to September 2010, Christophe worked at Charles River Laboratories, where responsibilities included Executive Vice President of Sales & Marketing, Chief Commercial Officer, Senior Vice President of RMS Operations, and General Manager. Christophe holds an Executive MBA in Management from Purdue University's Daniels School of Business and a Doctor of Veterinary Medicine degree from Ecole nationale vétérinaire de Lyon.